Trial intelligence / Profile preview

INTERACTION: Aspirin and Clopidogrel Interaction in Stable Patients With Previous MI or Stent

NCT01102439Phase 4Completed

Sponsor
Population Health Research Institute
Start
Apr 2010
Primary completion
Dec 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of clopidogrel and aspirin in coronary artery disease (CAD) (4 arms), sponsored by Population Health Research Institute. Primary endpoint: Blood concentrations of the active metabolite of clopidogrel at 14 days. Started Apr 2010; status: completed.

02

Drugs

clopidogrelaspirin
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01102439.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01102439.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call